BACKGROUND: The availability of novel direct-acting antivirals(DAAs) represents a new era of curative hepatitis C virus(HCV) treatment, with over 95% of patient
BACKGROUND: With the expansion of surgical criteria, the comparative efficacy between surgical resection(SR) and liver transplantation(LT) for hepatocellular ca